Celerion is listed on the portfolio pages of Court Square Capital Partners (portfolio page), H.I.G. Capital (portfolio page) and THL Partners (portfolio page). Court Square Capital Partners, H.I.G. Capital and THL Partners list it as current.
Celerion is a leading clinical research organization providing early phase clinical research, bioanalytical services, and drug development expertise.
Source: celerion.com, read November 2026
Celerion is a Healthcare company. Its owner on record, Court Square Capital Partners, is a buyout firm founded in 1968, headquartered in New York City, United States, with $8.2 billion under management. Court Square Capital Partners lists 255 companies in the index, 20 of them in Healthcare. Also backed by H.I.G. Capital and THL Partners.
Court Square Capital Partners is an American private equity firm that focuses on middle-market investments across various sectors including healthcare and industrials.
Read the Court Square Capital Partners profileH.I.G.
Read the H.I.G. Capital profilePrivate equity firm investing in middle-market growth companies.
Read the THL Partners profileCelerion is listed on the portfolio pages of Court Square Capital Partners (portfolio page), H.I.G. Capital (portfolio page) and THL Partners (portfolio page). Court Square Capital Partners, H.I.G. Capital and THL Partners list it as current.
Celerion is in Healthcare. Classified from the owner's portfolio label.
Court Square Capital Partners is headquartered in New York City, United States.
Court Square Capital Partners lists 19 other Healthcare companies in the index, including Advanced Diabetes Supply, AmeriSource Health Corporation, Arizant Healthcare, Eon Labs and Ergo Science.
Celerion's website is https://www.celerion.com/.
6 of 254 shown
See the full Court Square Capital Partners portfolio.
6 of 386 shown
See the full H.I.G. Capital portfolio.
6 of 99 shown
See the full THL Partners portfolio.
Browse PE-backed companies.
